TABLE 3.
Characteristics of the 43 included patients with HIT induced by LMWHs.
| Parameter | Value | Percentage (%) |
|---|---|---|
| Gender | ||
| Male | 12 | 27.91 |
| Female | 31 | 72.09 |
| Age (years) | ||
| <18 | 1 | 2.33 |
| 18–60 | 15 | 34.88 |
| >60 | 27 | 62.79 |
| Low-molecular-weight anticoagulant | ||
| Enoxaparin | 21 | 48.84 |
| Nadroparin | 14 | 32.56 |
| Dalteparin | 4 | 9.30 |
| Tinzaparin | 2 | 4.65 |
| Bemiparin | 2 | 4.65 |
| Primary disease | ||
| Embolism | 10 | 23.26 |
| Joint operation | 9 | 20.93 |
| Fracture | 5 | 11.63 |
| Surgery | 5 | 11.63 |
| Dialysis | 4 | 9.30 |
| Tumor | 3 | 6.98 |
| Heart failure | 3 | 6.98 |
| Traffic accident | 2 | 4.65 |
| Infection | 2 | 4.65 |
| Pregnancy | 1 | 2.33 |
| Medical history | ||
| Diabetes | 10 | 23.26 |
| Surgery | 9 | 20.93 |
| Obesity | 6 | 13.95 |
| Hypertension | 6 | 13.95 |
| Tumor | 4 | 9.30 |
| Chronic renal insufficiency | 3 | 6.98 |
| Myocardial disease | 3 | 6.98 |
| Cholecystectomy | 1 | 2.33 |
| Immune-related diseases | 1 | 2.33 |
| Thrombus history | 1 | 2.33 |
| No risk factors | 9 | 20.93 |
| Combined drugs | ||
| Antihypertensive drugs | 4 | 9.52 |
| Antidiabetic drugs | 2 | 4.76 |
| Antibiotics | 2 | 4.76 |
| Chemotherapeutic drugs | 1 | 2.38 |
| Other types of anticoagulants | 1 | 2.38 |
| Without other drugs | 36 | 85.71 |